Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Transdermal patch: 40 mg
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Esflurbiprofen as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
LocoaEsflurbiprofen | 40 mg Transdermal PatchAluminium foil laminated pouch (box x 7's) | Rx | Tokuhon Corporation (Miyashiro Factory)Japan | Taisho Pharmaceuticals (Philippines), Inc.Trader: Taisho Pharmaceutical Co., Ltd. | DR-XY48030 | May 20, 2027 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .